Taofei Zeng
2022–2022 OpenAlex profile ↗
Reproducibility track record
1
assessed papers
45/100
mean reproducibility
0
reproduced (C1–C2)
1
flagged
22
total citations
flag rate:
100%
(1/1)
The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.
Authorship role
first author: 1
last author: 0
Topics
Funders
—
Frequent co-authors
Lisha Sun 1Chaoliu Dai 1Xinbo Qiao 1Guanglei Chen 1Hui Chen 1Na Li 1Feng Xu 1Junqi Wang 1Qingtian Ma 1
Institutions
China Medical University 1Second Affiliated Hospital of Dalian Medical University 1
Geography (author institutions)
CN 1
Co-author network
Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.
How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.
Assessed papers (1)
Complete publication record (11)
Request a reproduction →1 assessed by us (0 reproduced) · 10 not yet assessed — every PubMed paper on record, linked below.
-
IFRD1 orchestrates hepatocyte metabolism and macrophage interactions to facilitate liver regeneration ↗Journal of Hepatology · 2026 · PMID 41861961not yet assessed
-
RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma ↗Nature Cancer · 2025 · PMID 40467995not yet assessed
-
Precision Visualization of Surgical Margins and Depth Imaging Performance in Orthotopic Hepatocellular Carcinoma Using Galactose-Targeted NIR-II Fluorescence Nanoprobe ↗Analytical Chemistry · 2025 · PMID 40590765not yet assessed
-
Author Correction: RIOK1 phase separation restricts PTEN translation via stress granules activating tumor growth in hepatocellular carcinoma ↗Nature Cancer · 2025 · PMID 40760122not yet assessed
-
IFRD1 promotes tumor cells “low-cost” survival under glutamine starvation via inhibiting histone H1.0 nucleophagy ↗Cell Discovery · 2024 · PMID 38802351not yet assessed
-
The diapause-like colorectal cancer cells induced by SMC4 attenuation are characterized by low proliferation and chemotherapy insensitivity ↗Cell Metabolism · 2023 · PMID 37543034not yet assessed
-
Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition ↗Frontiers in Immunology · 2023 · PMID 36685594not yet assessed
-
NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer⚑Frontiers in Pharmacology · 2022 · PMID 35431924L1 45/100 ⚑
-
Prognostic Value and Correlation With Tumor Immune Infiltration of a Novel Metabolism-Related Gene Signature in Pancreatic Cancer ↗Frontiers in Oncology · 2022 · PMID 35127473not yet assessed
-
The CD112R/CD112 axis: a breakthrough in cancer immunotherapy ↗Journal of Experimental & Clinical Cancer Research · 2021 · PMID 34507594not yet assessed
-
Genetic Association between Interleukin-4 Receptor Polymorphisms and Cancer Susceptibility: A Meta-Analysis Based on 53 Case-Control Studies ↗Journal of Cancer · 2019 · PMID 31031864not yet assessed
Full bibliography from OpenAlex; reproducibility verdicts matched by PMID.
Author attribution follows OpenAlex disambiguation, which is imperfect — a researcher's papers can be split across profiles or mixed with a namesake.
No ORCID on record to anchor it (≈⅓ of researchers have none), so this rests on name disambiguation alone. See every “Zeng T” paper on PubMed ↗